IPP Bureau
Max Healthcare to add over 300 beds in NCR ties up with Muthoot Hospitals
By IPP Bureau - January 20, 2022
The hospital will be operated under the name and style of Max Super Speciality Hospital, Dwarka
CliniSys creates world’s largest diagnostics and lab informatics with recent acquisitions
By IPP Bureau - January 19, 2022
CliniSys has the proven ability to deliver 100s of millions of medical results a month to enable pandemic-scale population disease surveillance across the globe
Lupin ties up with Foncoo of China
By IPP Bureau - January 19, 2022
This is the company’s first partnership arrangement in China
Lonza, Forbion, and BioGeneration to focus on manufacturing of small molecules
By IPP Bureau - January 19, 2022
The extended collaboration will provide services relating to small molecules for both Forbion and BGV portfolio companies active in the biopharmaceutical space
China approves MIOK Keratoprosthesis’ artificial cornea
By IPP Bureau - January 19, 2022
The artificial cornea is 100% made of non-biological materials and require no co-implantation of donor corneas and it is an ideal option for treating patients with corneal blindness
Imfinzi plus chemotherapy reduced risk of death by 20% in 1st-line advanced biliary tract cancer
By IPP Bureau - January 19, 2022
These results will be presented on 21 January at the 2022 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
Experts highlight positives of yoga in coping with Covid waves
By IPP Bureau - January 19, 2022
Yoga helps to build a strong immune system and daily breathing regime of 10-minute helps in the long run
Healthcare for seniors an opportunity for service providers
By IPP Bureau - January 19, 2022
Industry Report highlights the opportunities and need for multiple sectoral collaboration through 12 actionable recommendations under 6 thematic areas
Sauri Gudlavalleti is the new Chief Operating Officer of Sai Life Sciences
By IPP Bureau - January 19, 2022
He holds nine US patents and has published in multiple peer-reviewed journals and conferences
ICMR approves Krivida Novus RT-PCR kit
By IPP Bureau - January 19, 2022
Krivida Novus can detect the Omicron variant and its sub-lineages in 45 minutes
Menarini Diagnositcs PCR kit identifies Omicron variant
By IPP Bureau - January 18, 2022
It provides Covid-19 detection and Omicron surveillance in less than two hours
Abbisko Therapeutics enters global tie-up with Lilly to develop novel molecules
By IPP Bureau - January 18, 2022
The tie-up combines Abbisko Therapeutics’ proprietary drug discovery platform with Lilly’s disease and discovery expertise
Lupin to acquire supplements portfolio of Anglo-French Drugs & Industries for Rs 325 crore
By IPP Bureau - January 18, 2022
The acquisition would enable addition of established brands with high recall amongst healthcare professionals, especially in the vitamins, minerals and supplements category
Philips integrates cloud-based AI and 3D mapping into Zenition
By IPP Bureau - January 18, 2022
New capabilities on Philips Image Guided therapy mobile C-arm system – Zenition – and collaboration with Cydar offer the latest advances in endovascular treatment
.jpg "TPVI offers a ray of hope for children with Pulmonic Valve disease")
TPVI offers a ray of hope for children with Pulmonic Valve disease
By IPP Bureau - January 18, 2022
Extending nonsurgical treatment options for Failing Pulmonic Valve in patients with congenital heart disease using Transcatheter Pulmonary Valve
